A detailed history of Us Bancorp \De\ transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Us Bancorp \De\ holds 9,632 shares of TEVA stock, worth $164,803. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,632
Previous 23,036 58.19%
Holding current value
$164,803
Previous $374,000 53.74%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$15.81 - $18.96 $211,917 - $254,139
-13,404 Reduced 58.19%
9,632 $173,000
Q2 2024

Aug 06, 2024

BUY
$12.78 - $17.4 $189,731 - $258,320
14,846 Added 181.27%
23,036 $374,000
Q1 2024

May 07, 2024

BUY
$10.67 - $14.43 $46,542 - $62,943
4,362 Added 113.95%
8,190 $115,000
Q4 2023

Feb 09, 2024

BUY
$8.12 - $10.63 $8,306 - $10,874
1,023 Added 36.47%
3,828 $39,000
Q3 2023

Nov 03, 2023

BUY
$7.48 - $10.7 $7,330 - $10,486
980 Added 53.7%
2,805 $28,000
Q2 2023

Aug 09, 2023

SELL
$7.2 - $9.47 $59,724 - $78,553
-8,295 Reduced 81.97%
1,825 $13,000
Q1 2023

May 09, 2023

SELL
$8.36 - $11.37 $3,569 - $4,854
-427 Reduced 4.05%
10,120 $89,000
Q4 2022

Feb 13, 2023

SELL
$7.95 - $9.48 $1,256 - $1,497
-158 Reduced 1.48%
10,547 $96,000
Q3 2022

Oct 27, 2022

BUY
$6.86 - $11.95 $3,505 - $6,106
511 Added 5.01%
10,705 $87,000
Q2 2022

Aug 01, 2022

SELL
$7.38 - $10.4 $8,405 - $11,845
-1,139 Reduced 10.05%
10,194 $77,000
Q1 2022

May 11, 2022

SELL
$7.33 - $9.39 $2,675 - $3,427
-365 Reduced 3.12%
11,333 $106,000
Q4 2021

Feb 11, 2022

BUY
$7.9 - $10.19 $1,437 - $1,854
182 Added 1.58%
11,698 $94,000
Q3 2021

Nov 10, 2021

SELL
$8.38 - $10.18 $8,304 - $10,088
-991 Reduced 7.92%
11,516 $112,000
Q2 2021

Aug 05, 2021

SELL
$9.9 - $11.56 $19,404 - $22,657
-1,960 Reduced 13.55%
12,507 $124,000
Q1 2021

Apr 28, 2021

SELL
$10.34 - $12.81 $16,016 - $19,842
-1,549 Reduced 9.67%
14,467 $167,000
Q4 2020

Feb 04, 2021

SELL
$8.61 - $11.04 $1,722 - $2,208
-200 Reduced 1.23%
16,016 $155,000
Q3 2020

Nov 10, 2020

SELL
$8.57 - $12.69 $23,850 - $35,316
-2,783 Reduced 14.65%
16,216 $146,000
Q2 2020

Aug 07, 2020

SELL
$8.12 - $13.12 $4,181 - $6,756
-515 Reduced 2.64%
18,999 $234,000
Q1 2020

May 13, 2020

BUY
$6.69 - $13.45 $51,887 - $104,318
7,756 Added 65.96%
19,514 $175,000
Q4 2019

Feb 04, 2020

SELL
$6.53 - $10.72 $17,546 - $28,804
-2,687 Reduced 18.6%
11,758 $115,000
Q3 2019

Nov 08, 2019

SELL
$6.16 - $9.6 $76,704 - $119,539
-12,452 Reduced 46.3%
14,445 $99,000
Q2 2019

Aug 13, 2019

SELL
$8.12 - $15.72 $146,655 - $283,918
-18,061 Reduced 40.17%
26,897 $248,000
Q1 2019

May 08, 2019

SELL
$15.58 - $20.01 $1.23 Million - $1.58 Million
-79,135 Reduced 63.77%
44,958 $705,000
Q4 2018

Feb 13, 2019

SELL
$14.59 - $23.84 $609,964 - $996,678
-41,807 Reduced 25.2%
124,093 $1.91 Million
Q3 2018

Nov 01, 2018

BUY
$21.06 - $25.65 $369,160 - $449,618
17,529 Added 11.81%
165,900 $3.57 Million
Q2 2018

Aug 08, 2018

BUY
$16.77 - $24.71 $1.69 Million - $2.48 Million
100,518 Added 210.06%
148,371 $3.61 Million
Q1 2018

May 08, 2018

SELL
$16.68 - $22.07 $53,059 - $70,204
-3,181 Reduced 6.23%
47,853 $818,000
Q4 2017

Feb 02, 2018

SELL
$11.23 - $19.1 $340,695 - $579,455
-30,338 Reduced 37.28%
51,034 $968,000
Q3 2017

Nov 13, 2017

BUY
$15.41 - $32.17 $1.25 Million - $2.62 Million
81,372
81,372 $1.43 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.